Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Ultrastructural Evaluation of Fractional CO₂ Laser in the Treatment of Primary Cutaneous Amyloidosis: A Randomized, Controlled Clinical Study

NCT07815132 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07815132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Ultrastructural Evaluation of Fractional CO₂ Laser in the Treatment of Primary Cutaneous Amyloidosis: A Randomized, Controlled Clinical Study
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2024
Completion date
August 10, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid, fractional, laser